Medical Conferences
December 06 - 7, 2024
December 06 - 7, 2024
December 12 - 15, 2024
MTF Biologics has provided safe, high-quality allografts for more than 35 years, first for orthopedic applications and more recently for plastic & reconstructive surgery and wound care procedures. Through speaking to medical professionals like yourself, we’ve come to learn that many of the more than 2,700 allografts we distribute in these three markets also have uses in craniofacial surgery.
We never use terminal sterilization in any of our tissue processes due to the demonstrated negative effects it can have on bone, cartilage, and soft tissues. Instead, our allografts are aseptically
processed to meet USP <71>
standards, the same standards established to ensure the sterility of sterile saline, chemotherapy drugs, and other agents used in hospitals every day.
Our donor recovery standards are among the most stringent in the industry, going above FDA and conventional standards for 30 criteria, including cancer and illegal drug use. In fact, we accept less than 2% of donor tissue offered to us through our relationships with more than 30 organ and tissue procurement agencies across the U.S.
Our portfolio of cortical and cortical-cancellous grafts are intended for use in a variety of surgical applications. They may be utilized in craniofacial procedures, including genioplasty, orthognathic surgery, cranial vaulting, and cleft palate repair.
Derived from costal cartilage and meniscus, these grafts are intended for use in a variety of surgical applications. They may be utilized in craniofacial procedures, including rhinoplasty in adults, children born with cleft palate, ear reconstruction for microtia, and reconstructive procedures for hemifacial microsomia and Treacher Collins syndrome, among other applications.
Soft tissue grafts are intended for the replacement of damaged or inadequate integumental tissue or for the repair, reinforcement or supplemental support of soft tissue defects. These tissues may be utilized in craniofacial procedures, including craniostenosis, balancing asymmetries from Parry-Romberg, treating post-MOHs wounds, and a wide variety of soft tissue defects.
MTF Biologics entered the plastic & reconstructive surgery field because of surgeons like you. We built our
reputation in other markets,
such as Orthopedics and Sports Medicine, before extending into plastic surgery and non-surgical aesthetics. We listened—learning about
the challenges you most commonly face. Since then, we’ve developed ADMs, nose-reshaping grafts, and more—all designed with you and your patients in mind.
If you are a U.S.
healthcare professional and need more information, please complete our Healthcare Professional Form.
